Burning Mouth Syndrome, the Oral Microbiome, and Lactic Acid Bacteria: A Comprehensive Review of Clinical Features, Microbial Dysbiosis, and Probiotic Therapeutic Potential
Open Access
- 29 June 2026
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 14 (7) , 1420
Abstract
Background: Burning mouth syndrome (BMS) is a chronic orofacial pain disorder characterized by persistent intraoral burning recurring daily for at least 2 h over more than 3 months, without explanatory mucosal or laboratory findings. It affects 1.7–7.7% of the population, predominantly perimenopausal and postmenopausal women, and conventional pharmacotherapy offers only partial relief. Aim: This narrative review examines the associative and mechanistic evidence linking the oral microbiome to BMS and evaluates the rationale for lactic acid bacteria (LAB) as a candidate therapeutic strategy. Methods: PubMed/MEDLINE, Scopus, and Web of Science were searched for English-language literature on BMS, the oral microbiome, and probiotics, supplemented by mechanistic data from related conditions. Results: BMS patients may exhibit a compositionally distinct salivary microbiome, with reduced alpha diversity in psychiatric-comorbid subsets, though findings are heterogeneous. LAB, particularly Lacticaseibacillus paracasei, show antimicrobial and immunomodulatory properties relevant to oral homeostasis, but direct clinical evidence in BMS remains scarce and largely preclinical. Conclusions: Current evidence is predominantly cross-sectional and associative; the oral dysbiosis–BMS link and the therapeutic potential of LAB should be regarded as hypothesis-generating, warranting biomarker-anchored, strain-specific randomized trials.Keywords
This publication has 77 references indexed in Scilit:
- Efficacy of different therapeutic options for pain relief and treatment of burning mouth syndrome: a systematic reviewClinical Oral Investigations, 2025
- Managing Burning Mouth Syndrome: Current and Future DirectionsDrugs, 2025
- Micronutrients status as a contributing factor in secondary burning mouth syndrome: A review of the literatureHealth Science Reports, 2024
- The efficacy of alpha‐lipoic acid in the management of burning mouth syndrome: An updated systematic review of randomized controlled clinical trialsHealth Science Reports, 2023
- COVID-19-Related Burning Eye Syndrome and Burning Mouth Syndrome: A Systematic Review and Meta-analysisPain and Therapy, 2023
- Salivary metabolomics of burning mouth syndrome: A cross-sectional studyArchives of Oral Biology, 2022
- Whole-genome sequence and comparative genome analysis of Lactobacillus paracasei DTA93, a promising probiotic lactic acid bacteriumArchives of Microbiology, 2020
- Consumption of Lactobacillus reuteri‐containing lozenges improves periodontal health in navy sailors at sea: A randomized controlled trialJournal of Periodontology, 2020
- A double‐blind study on clonazepam in patients with burning mouth syndromeThe Laryngoscope, 2012
- Molecular Characterization of a Novel Bacteriocin and an Unusually Large Aggregation Factor of Lactobacillus paracasei subsp. paracasei BGSJ2-8, a Natural Isolate from Homemade CheeseCurrent Microbiology, 2007